COPD: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

EU-13 is a filter, not a ranking: it only narrows the list.

24 of 200+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

No stopped trial with a stated reason in this view.

Trials whose registry record says individual participant data (IPD) will be shared.

• A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)

  NCT07780656· GlaxoSmithKline· Source

• A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

  NCT07759245· Eli Lilly and Company· Source

• A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)

  NCT07780669· GlaxoSmithKline· Source

• Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD

  NCT07051707· Nuvaira, Inc.· Source

• WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department

  NCT07558265· Ohio State University· Source

• Comprehensive Maintenance Program: a Health Haven for COPD in Lleida.The NAPOLEON Project.

  NCT07394712· Institut de Recerca Biomèdica de Lleida· Source

• A Study to Assess the Efficacy and Safety of Co-administration of GSK3862995B With GSK5784283 in Adult Participants With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

  NCT07915791· GlaxoSmithKline· Source

• Effect of Ensifentrine (MK-5884/RPL554) on Sputum Markers of Inflammation in Chronic Obstructive Pulmonary Disease (COPD) (MK-5884-023/RPL554-CO-207)

  NCT05270525· Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA· Source

• Firefighter's Longitudinal Airway and Respiratory Exposome/Multiome Study (FLARES)

  NCT07867184· National Institute of Allergy and Infectious Diseases (NIAID)· Source

• The AIRWARD Study: A Study to Test Whether Verducatib Helps People With Chronic Obstructive Pulmonary Disease

  NCT07907991· Boehringer Ingelheim· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 25
• Organoids 7
• Mendelian Randomization Analysis 68
• CRISPR-Cas Systems 1
• Gene Expression Profiling 68
• Sequence Analysis, RNA 7
• Whole Genome Sequencing 4
• Proteomics 31
• Metabolomics 34
• Mass Spectrometry 5
• Flow Cytometry 5
• Immunohistochemistry 5
• Liquid Biopsy 2
• Circulating Tumor DNA 1
• Magnetic Resonance Imaging 32
• Machine Learning 102
• Deep Learning 33
• Cohort Studies 225
• Genome-Wide Association Study 71

• Integrative Single-Cell and Bulk RNA Sequencing Analysis Identifies Ion Channel-Related Biomarkers in Chronic Obstructive Pulmonary Disease.

  Int J Chron Obstruct Pulmon Dis, Oct 2026

• Single-cell analysis of COPD: Microenvironmental interactions driven by immune-fibrotic imbalance.

  PLoS One, Oct 2026

• Single-Cell Transcriptomics Reveals Macrophage Dysfunction and cDC2 Activation in COPD: Candidate Biomarkers for Individualized Nursing Care.

  Int J Chron Obstruct Pulmon Dis, Oct 2026

• Identification and Validation of a Two-Gene NK Cell-Related Risk Model for COPD: Integration of Single-Cell and Bulk RNA-Seq Analysis.

  Int J Chron Obstruct Pulmon Dis, Sept 2026

• Genetic Liability to COPD and Periodontitis Risk: Integrative Genetic and Single-Cell Evidence Implicating Macrophage Reprogramming.

  Int J Chron Obstruct Pulmon Dis, Sept 2026

• Integrative Transcriptomic Analysis and Single-Cell Characterization Identify RTN4 as a Candidate PBMC-Derived Hub Gene Associated with COPD and Coronary Artery Disease.

  Genes (Basel), Aug 2026

• Airway cell-cell communication in smoking through integration of spatial and single-cell transcriptomics.

  Respir Res, Aug 2026

• Single-cell sequencing unveils a profibrotic macrophage and infiltrating monocyte niche in the bronchoalveolar lavage of patients with chronic obstructive pulmonary disease.

  Am J Respir Crit Care Med, Aug 2026

• Integrative machine learning and single-cell analysis identifies nicotine-related diagnostic genes and myeloid remodeling in COPD.

  Front Immunol, Jul 2026

• Single‑cell and spatial transcriptomics in chronic lung disease: cellular heterogeneity and molecular mechanisms in IPF and COPD.

  Respir Res, Jul 2026

See which targets of this disease your abstract mentions, and go to the people working on them.